Skip to content
Research Article Open access CC BY 4.0

A Summary of the Advances in Ophthalmic Drug Delivery via Iontophoresis and Microneedles

Daniel Vettori

British Journal of Pharmaceutical Research · pp. 1–7 · Published 10 Jan 2016

10.9734/bjpr/2016/30601

Abstract

Drug delivery to the posterior segment of the eye is a significantly challenging task due to the underlying physiological, anatomical and metabolic constraints. Delivery of drugs through ophthalmic route is significantly hindered by multiple physiological processes including potential static and dynamic barriers. Moreover, efflux pumps expressed on ocular tissues severely restrict the intra-ocular penetration of drugs, especially into the posterior ocular tissues. However, severe ocular complications which may be sight threatening, pose an urgency for the intervention/ treatment. Currently, invasive intravitreal injections are widely used to drugs/drug candidates to retina and vitreous body. Therefore, non-invasive drug delivery strategies that overcome the barriers encountered in the ocular milieu should be developed and explored. Various topical formulation approaches are being designed in order to address the safety and patient compliance issues associated with invasive routes. In this review, the targeted drug delivery to the ocular posterior segment via minimally invasive approaches is discussed.

Pharmacy Pharmacogenomics Medicine Pharmacology Clinical pharmacology Family medicine

References (27)

  1. 1 Ocular drug delivery [DOI]
  2. 2 Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow Microneedles [DOI]
  3. 3 Iontophoresis: electrorepulsion and electroosmosis [DOI]
  4. 4 Intrascleral Drug Delivery to the Eye Using Hollow Microneedles [DOI]
  5. 5 Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues [DOI]
  6. 6 Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications [DOI]
  7. 7 Tolerance of Ocular Iontophoresis in Healthy Volunteers [DOI]
  8. 8 Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments [DOI]
  9. 9 Methylprednisolone Delivery to the Back of the Eye using Hydrogel Iontophoresis [DOI]
  10. 10 Emerging therapies for the treatment of ungual onychomycosis [DOI]
  11. 11 PDMS embedded microneedles as a controlled release system for the eye [DOI]
  12. 12 The Role of Iontophoresis in Ocular Drug Delivery [DOI]
  13. 13 Ocular drug delivery in veterinary medicine [DOI]
  14. 14 A flexible device for ocular iontophoretic drug delivery [DOI]
  15. 15 Trans-ungual delivery of itraconazole hydrochloride by iontophoresis [DOI]
  16. 16 Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery [DOI]
  17. 17 Effect of Cyclodextrins on Morphology and Barrier Characteristics of Isolated Rabbit Corneas [DOI]
  18. 18 Brain-derived neurotrophic factor response in vulnerable and resilient genetic lines in the chick anxiety–depression model [DOI]
  19. 19 Development of nano structured lipid carriers of ciprofloxacin for ocular delivery : Characterization, in vivo distribution and effect of PEGylation.
  20. 20 Development and evaluation of prolonged release topical indomethacin formulations for ocular inflammation
  21. 21 A Fresh Look at Iontophoresis [DOI]
  22. 22 Transscleral Iontophoresis of Dexamethasone [DOI]
  23. 23 Ocular Disposition of Ganciclovir and Its Monoester Prodrugs following Intravitreal Administration Using Microdialysis [DOI]
  24. 24 Iontophoretic Delivery of Carboplatin in a Murine Model of Retinoblastoma [DOI]
  25. 25 An ocular iontophoretic device using PEDOT electrode for local drug delivery [DOI]
  26. 26 Iontophoresis, a Scientific and Practical Tool in Ophthalmology [DOI]
  27. 27 [Considerations on the use of corticoids by ionization in certain ocular diseases].

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

58

Page views

0

PDF downloads

13

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.